Loading...
Statistical Considerations in the Design of Biosimilar Cancer Clinical Trials
When the patent of an innovative (brand-name) small-molecule drug expires, generic copies of the innovative drug may be marketed if their therapeutic equivalence to the innovative drug has been shown. The small-molecule drugs are considered therapeutically equivalent and can be used interchangeably...
Na minha lista:
| Main Authors: | , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
2011
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3691070/ https://ncbi.nlm.nih.gov/pubmed/23805045 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5351/KJAS.2011.24.3.495 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|